FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16111711000001101: BackOsamine tablets (William Ransom & Son Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57017501000001119 BackOsamine tablets (William Ransom & Son Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
66150801000001118 BackOsamine tablets (Optima Consumer Health Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
BackOsamine tablets (William Ransom & Son Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
BackOsamine tablets (William Ransom & Son Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
BackOsamine tablets (William Ransom & Son Plc) Is a Generic BackOsamine tablets true Inferred relationship Existential restriction modifier
BackOsamine tablets (William Ransom & Son Plc) VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
BackOsamine tablets (William Ransom & Son Plc) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
BackOsamine tablets (William Ransom & Son Plc) Has specific active ingredient Chondroitin sulfate true Inferred relationship Existential restriction modifier
BackOsamine tablets (William Ransom & Son Plc) Has specific active ingredient Ascorbic acid true Inferred relationship Existential restriction modifier
BackOsamine tablets (William Ransom & Son Plc) Has specific active ingredient Bromelains true Inferred relationship Existential restriction modifier
BackOsamine tablets (William Ransom & Son Plc) Has specific active ingredient Glucosamine sulphate false Inferred relationship Existential restriction modifier
BackOsamine tablets (William Ransom & Son Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
BackOsamine tablets (William Ransom & Son Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
BackOsamine tablets (William Ransom & Son Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
BackOsamine tablets (William Ransom & Son Plc) Is a BackOsamine true Inferred relationship Existential restriction modifier
BackOsamine tablets (William Ransom & Son Plc) Has active ingredient Glucosamine true Inferred relationship Existential restriction modifier
BackOsamine tablets (William Ransom & Son Plc) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
BackOsamine tablets (William Ransom & Son Plc) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
BackOsamine tablets (William Ransom & Son Plc) Has specific active ingredient Glucosamine sulfate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
BackOsamine tablets (William Ransom & Son Plc) 60 tablet 4 x 15 tablets Has AMP True BackOsamine tablets (William Ransom & Son Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start